You have 9 free searches left this month | for more free features.

Novel Cancer Vaccine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Host Immune Response to Novel RNA COVID-19 Vaccination

Recruiting
  • COVID-19 Vaccine
  • Cancer
  • COVID-19 Vaccine
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
Apr 22, 2022

Colorectal Cancer Metastatic Trial (EO2401)

Not yet recruiting
  • Colorectal Cancer Metastatic
  • (no location specified)
Feb 2, 2023

Follicular Lymphoma, Marginal Zone Lymphoma Trial in Italy, Spain, United States (EO2463, lenalidomide, rituximab)

Recruiting
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • EO2463
  • +2 more
  • Boston, Massachusetts
  • +9 more
Jul 26, 2022

Cervical Intraepithelial Neoplasia, Cervical Dysplasia Trial in New Haven (9-valent HPV vaccine, Imiquimod)

Active, not recruiting
  • Cervical Intraepithelial Neoplasia
  • Cervical Dysplasia
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 5, 2022

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus vaccine (CHO Cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 6, 2023

Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel

Not yet recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • (no location specified)
Sep 5, 2023

Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)

Recruiting
  • Adrenocortical Carcinoma
  • +2 more
  • EO2401
  • Houston, Texas
  • +9 more
Dec 7, 2021

Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

Active, not recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
May 6, 2023

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma Trial in United States (PEP-CMV, Temozolomide,

Not yet recruiting
  • High Grade Glioma
  • +2 more
  • PEP-CMV
  • +2 more
  • Aurora, Colorado
  • +9 more
Jan 28, 2022

Polio Trial (polio vaccines: nOPV2, bOPV, IPV)

Not yet recruiting
  • Polio
  • polio vaccines: nOPV2, bOPV, IPV
  • (no location specified)
Nov 2, 2023

Urinary and Vaginal HPV Testing in Cervical Cancer Screening

Not yet recruiting
  • Uterine Cervical Neoplasms
  • urine self-sampling group
  • clinician-collected cervical sample group
  • (no location specified)
Oct 1, 2021

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

Poliomyelitis Trial in Dhaka (Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1), Sabin Monovalent Oral

Not yet recruiting
  • Poliomyelitis
  • Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1)
  • Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research, Bangladesh
Nov 30, 2022

COVID-19 Trial in Tashkent (Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells), Recombinant Novel

Recruiting
  • COVID-19
  • Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
  • Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
  • Tashkent, Uzbekistan
    Uzbekistan, Tashkent city, Said baraka street 10
Nov 11, 2022

Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral

Not yet recruiting
  • Poliomyelitis
  • Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
  • Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
  • Panama City, Panama
  • +3 more
Dec 14, 2022

COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
  • Taizhou, Jiangsu, China
    Taixing City center for Disease Control and Prevention
Oct 28, 2022

Poliomyelitis Trial in United States (Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin

Active, not recruiting
  • Poliomyelitis
  • Novel Oral Polio Vaccine Type 1 (nOPV1)
  • +3 more
  • Baltimore, Maryland
  • +3 more
Aug 24, 2022

COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

Active, not recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
  • Yancheng, Jiangsu, China
    Funing Center for Disease Control and Prevention
Oct 28, 2022

Corona Virus Disease 2019(COVID-19) Trial in Chengdu (0.3ml of mRNA vaccine)

Enrolling by invitation
  • Corona Virus Disease 2019(COVID-19)
  • 0.3ml of mRNA vaccine
  • Chengdu, China
    West China Second University Hospital
Oct 3, 2022

Influenza Trial in Ghent (TETRALITE)

Active, not recruiting
  • Influenza
  • TETRALITE
  • Ghent, Belgium
    CEVAC, University Hospital
Nov 16, 2022

Glioblastoma, Adult Trial in Worldwide (Multiple dose of EO2401)

Recruiting
  • Glioblastoma, Adult
  • Multiple dose of EO2401
  • Boston, Massachusetts
  • +9 more
Dec 7, 2021

COVID-19 Vaccines Trial in Hannover (MVA-SARS-2-ST)

Recruiting
  • COVID-19 Vaccines
  • MVA-SARS-2-ST
  • Hannover, Germany
    Hannover Medical School ZKS - Early Clinical Trial Unit at CRC H
Sep 6, 2022

Rabies, Rabies Immunisation Trial in Decatur (ChAd155-RG, Placebo, Rabies Vaccine)

Active, not recruiting
  • Rabies
  • Rabies Immunisation
  • ChAd155-RG
  • +2 more
  • Decatur, Georgia
    Emory Vaccine Center - The Hope Clinic
Aug 18, 2022

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023